Journal of Natural Products · 2018 · 11 citations · 15 references
PharmacyMedicinal ChemistryPharmacologyCancer PharmacologyDrug DiscoveryStructure-activity RelationshipsEnzyme InhibitionMedicinal PlantsAnticancer ActivityBioactive Plant CompoundsDrug Transporter OverexpressionExtractIsoquinoline AlkaloidsMedicinal HerbsPlant AlkaloidsSecondary Metabolites
Alangium longiflorum is currently in extinction crisis, which will likely severely hamper further phytochemical investigation of this plant species from new collections. A crude extract of leaves of A. longiflorum (N33539), collected for the U.S. National Cancer Institute in 1989, showed potent cancer cell line antiproliferative activity. A phytochemical study resulted in the isolation of 17 secondary metabolites, including two new tetrahydroisoquinoline alkaloids, 8-hydroxytubulosine (1) and 2'- O- trans-sinapoylisoalangiside (2), as well as a new sinapolyloxylupene derivative (3). Using in-house assays and NCI-60 panel screening, compound 1 displayed broad-spectrum inhibitory activity at submicromolar levels against most tested tumor cell lines, except for drug-transporter-overexpressing cells. Compound 1 caused accumulation of sub-G1 cells with no effect on cell cycle progression, suggesting that this substance is an apoptosis inducer.
15
Iridoids. An Updated Review. Part I.
Christie A. Boros, Frank R. Stermitz · Journal of Natural Products · 1990 · 277 citations
Yôichi Nakatani, Guy Ourisson, Jean-Paul Beck · Chemical and Pharmaceutical Bulletin · 1981 · 75 citations · Full text